OptimizeRx Reports Second Quarter 2023 Financial Results
August 14, 2023 16:01 ET
|
OptimizeRx Corporation
– RWD.AI-enabled portion of the core business sees 186% YOY growth during the first half of 2023 – Non-core business is lagging – Total revenue of $13.8 million – GAAP net loss...
OptimizeRx Sets Second Quarter 2023 Conference Call for August 14, 2023 at 4:30 p.m. ET
July 31, 2023 08:01 ET
|
OptimizeRx Corporation
ROCHESTER, Mich., July 31, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx’s CEO Provides 2023 Midyear Strategic Update
May 24, 2023 07:30 ET
|
OptimizeRx Corporation
A leading suite of pharma tech solutions combined with deep brand penetration is driving revenue growth, resulting in improved profitability and KPIs through the remainder of 2023 and beyondWith a...
OptimizeRx’s Karina Castagna Named One of the 2023 PM360 ELITE 100
May 18, 2023 08:01 ET
|
OptimizeRx Corporation
ROCHESTER, Mich., May 18, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx to Participate in Upcoming Investor Conferences
May 15, 2023 08:00 ET
|
OptimizeRx Corporation
ROCHESTER, Mich., May 15, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx Reports First Quarter 2023 Financial Results
May 10, 2023 16:01 ET
|
OptimizeRx Corporation
Total revenue of $13.0 millionGAAP net loss per share of $(0.37)Non-GAAP net loss per share of $(0.09) ROCHESTER, Mich., May 10, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq:...
Surveyed Physicians Spell Out Preferences for Data-driven, Omnichannel Content That Delivers Clinical Relevance
May 02, 2023 08:00 ET
|
OptimizeRx Corporation
ROCHESTER, Mich., May 02, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx Sets First Quarter 2023 Conference Call for May 10, 2023at 4:30 p.m. ET
April 26, 2023 08:00 ET
|
OptimizeRx Corporation
ROCHESTER, Mich., April 26, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx Releases 2023 Environmental, Social and Governance (ESG) Report
April 04, 2023 08:01 ET
|
OptimizeRx Corporation
ROCHESTER, Mich., April 04, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
Financial Times Ranks OptimizeRx Amongst The Americas’ Fastest Growing Companies for the Fourth Consecutive Year
March 29, 2023 09:20 ET
|
OptimizeRx Corporation
ROCHESTER, Mich., March 29, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...